The COVID-19 pandemic provided unexpected momentum towards the pharmaceutical research industry: the health crisis brought enormous attention and created the opportunity to explain contexts and background of pharmaceutical research and production. During this time, we created a green paper as a reason and a vehicle for high-level stakeholder talks. We coordinated and guided nearly 40 interviews with the most vital decision-makers of the health sector, which gave the leadership of the Association of the Research & Development based Pharmaceutical Industry in Austria (FOPI) the opportunity to hold a conversation at eye level. Edited professionally, the statements were published in the green paper, which is available in print and online. Presented during a virtual event with over 200 participants, it was a tremendously effective instrument for FOPI.